首页 | 本学科首页   官方微博 | 高级检索  
     

大剂量甲氨喋呤联合消瘤芥治疗复发难治性恶性淋巴瘤12例临床观察
引用本文:张明智,郑晓珂,耿丽,李鑫. 大剂量甲氨喋呤联合消瘤芥治疗复发难治性恶性淋巴瘤12例临床观察[J]. 肿瘤基础与临床, 2006, 19(3): 223-224
作者姓名:张明智  郑晓珂  耿丽  李鑫
作者单位:郑州大学第一附属医院肿瘤科,河南,郑州,450052;郑州大学第一附属医院肿瘤科,河南,郑州,450052;郑州大学第一附属医院肿瘤科,河南,郑州,450052;郑州大学第一附属医院肿瘤科,河南,郑州,450052
摘    要:目的观察大剂量甲氨喋呤(MTX)联合消瘤芥(AT-1258)治疗复发难治性恶性淋巴瘤的效果及毒副反应。方法观察12例复发难治性淋巴瘤患者,给予MTX 2~3 g/m2联合AT-1258 20~40 mg化疗,同时给予水化、碱化、利尿、保肝及营养支持治疗。结果4例霍奇金淋巴瘤近期有效率为75%,8例非霍奇金淋巴瘤近期有效率为62.5%,总有效率为66.7%,未发生严重的毒副反应。结论大剂量甲氨喋呤联合消瘤芥治疗复发难治性恶性淋巴瘤是一种安全有效的方案。

关 键 词:大剂量甲氨喋呤  消瘤芥  恶性淋巴瘤
文章编号:1673-5412(2006)03-0223-02
收稿时间:2005-01-16
修稿时间:2005-01-16

The Clinical Observation of the Effect and Toxic Reactions of High-Dose Methotrexate plus Nitrocaphane Chemotherapy in Refractory or Relapsed Malignant Lymphoma
Zhang Mingzhi,Zheng Xiaoke,Geng Li,Li Xin. The Clinical Observation of the Effect and Toxic Reactions of High-Dose Methotrexate plus Nitrocaphane Chemotherapy in Refractory or Relapsed Malignant Lymphoma[J]. Journal of Basic and Clinical Oncology, 2006, 19(3): 223-224
Authors:Zhang Mingzhi  Zheng Xiaoke  Geng Li  Li Xin
Affiliation:Department of Oncology, The First Affliated Hospital of Zhengzhou University , Zhengzhou 450052, China
Abstract:Objective To observe the treatment outcome and toxic reactions of high-dose methotrexate combined with AT-1258 chemotherapy for the patients with refractory or relapsed lymphoma.Methods 12 chosen patients were treated with MTX 2-3g/m~2 combined with AT-1258 20-40mg,and were given hydration,alkalization,diuresis,hepar protection at the same time.Results The overall response rate was 66.7%,and no serious toxic reactions happened.Conclusion High-dose methotrexate combined with AT-1258 chemotherapy appeared to be an effective and safe regimen for patients with refractory or relapsed lymphoma.
Keywords:high-dose methotrexate  AT-1258  malignant lymphoma
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号